HIV-associated neurocognitive disorder—pathogenesis and prospects for treatment

D Saylor, AM Dickens, N Sacktor, N Haughey… - Nature Reviews …, 2016 - nature.com
In the past two decades, several advancements have improved the care of HIV-infected
individuals. Most importantly, the development and deployment of combination antiretroviral …

[HTML][HTML] Mental health and HIV/AIDS: the need for an integrated response

RH Remien, MJ Stirratt, N Nguyen, RN Robbins… - Aids, 2019 - journals.lww.com
Tremendous biomedical advancements in HIV prevention and treatment have led to
aspirational efforts to end the HIV epidemic. However, this goal will not be achieved without …

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors

RK Heaton, DR Franklin, RJ Ellis, JA McCutchan… - Journal of …, 2011 - Springer
Combination antiretroviral therapy (CART) has greatly reduced medical morbidity and
mortality with HIV infection, but high rates of HIV-associated neurocognitive disorders …

Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives

DJ Baker, RC Petersen - The Journal of clinical …, 2018 - Am Soc Clin Investig
Along with a general decline in overall health, most chronic degenerative human diseases
are inherently associated with increasing age. Age-associated cognitive impairments and …

Global prevalence and burden of HIV-associated neurocognitive disorder: a meta-analysis

Y Wang, M Liu, Q Lu, M Farrell, JM Lappin, J Shi, L Lu… - Neurology, 2020 - AAN Enterprises
Objective To characterize the prevalence and burden of HIV-associated neurocognitive
disorder (HAND) and assess associated factors in the global population with HIV. Methods …

Neuroimmune axes of the blood–brain barriers and blood–brain interfaces: bases for physiological regulation, disease states, and pharmacological interventions

MA Erickson, WA Banks, R Dantzer - Pharmacological reviews, 2018 - Elsevier
Central nervous system (CNS) barriers predominantly mediate the immune-privileged status
of the brain, and are also important regulators of neuroimmune communication. It is …

Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: a cross-sectional study

M Gisslén, RW Price, U Andreasson, N Norgren… - …, 2016 - thelancet.com
Background Cerebrospinal fluid (CSF) neurofilament light chain protein (NFL) is a sensitive
marker of neuronal injury in a variety of neurodegenerative conditions, including the CNS …

Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study

N Sacktor, RL Skolasky, E Seaberg, C Munro… - Neurology, 2016 - AAN Enterprises
Objective: To evaluate the frequency of HIV-associated neurocognitive disorder (HAND) in
HIV+ individuals and determine whether the frequency of HAND changed over 4 years of …

HIV-associated neurocognitive disorder

DB Clifford, BM Ances - The Lancet infectious diseases, 2013 - thelancet.com
Neurological involvement in HIV is often associated with cognitive impairment. Although
severe and progressive neurocognitive impairment has become rare in HIV clinics in the era …

Central nervous system viral invasion and inflammation during acute HIV infection

V Valcour, T Chalermchai, N Sailasuta… - The Journal of …, 2012 - academic.oup.com
Background. Understanding the earliest central nervous system (CNS) events during human
immunodeficiency virus (HIV) infection is crucial to knowledge of neuropathogenesis, but …